stockrowMedline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
Follow MDLN
Alert me
Medline Inc. (MDLN) EV/EBITDA
As of 5 November 2026, Medline Inc. (MDLN) trades at a EV/EBITDA of 4.5×. Over the past ten years it has ranged from 0.0× (March 2026) to 4.9× (April 2026); the current reading is higher than 86% of that period. That is below the Medical Instruments & Supplies industry median of 14.9× and below the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 4.0× | (7.74%) |
| Jun 2026 | 4.4× | (5.02%) |
| Mar 2026 | 4.6× | — |
| Dec 2025 | 0.0× | — |
| 2 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| MDLN Medline Inc. | 4.5× |
| SOLV Solventum Corporation compare | 7.6× |
| BAX Baxter International Inc. compare | 13.2× |
| ALC Alcon compare | 14.8× |
| BDX Becton, Dickinson and Company compare | 14.9× |
| RMD ResMed Inc. compare | 15.7× |
| COO The Cooper Companies, Inc. compare | 15.8× |
| WST West Pharmaceutical Services, Inc. compare | 28.4× |
| ISRG Intuitive Surgical, Inc. compare | 38.3× |
| Medical Instruments & Supplies industry median | 14.9× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement